Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

738
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
738
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

440
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
440
GPCR Desensitization01:12

GPCR Desensitization

5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.6K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.6K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

1.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Coordinated Subpocket Engagement Underlies Nitazene Potency at the μ-Opioid Receptor.

ACS chemical neuroscience·2026
Same author

Mn(III)-Catalyzed Synthesis of Selenophosphates and Tellurophosphates.

Molecules (Basel, Switzerland)·2026
Same author

Small-molecule modulation of β-arrestins.

Nature·2026
Same author

Divergent activation of the RXFP1 relaxin receptor by protein and small molecule agonists.

bioRxiv : the preprint server for biology·2026
Same author

Transformer-based framework uncovers state-dependent modular organization and conformational landscapes of the β-arrestin 1 C-terminal tail.

bioRxiv : the preprint server for biology·2026
Same author

Sympathetic immunomodulation suppresses liver metastasis by maintaining the balance between norepinephrine concentration and the α2a/β2-AR ratio.

Cellular & molecular immunology·2026

相关实验视频

Updated: May 7, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.8K

小分子调节器β-阿雷斯的小分子调节器

Alem W Kahsai, Natalia Pakharukova, Henry Y Kwon

    bioRxiv : the preprint server for biology
    |January 7, 2025
    PubMed
    概括
    此摘要是机器生成的。

    研究人员开发了新型的小分子,可以抑制β-arrestins (βarrs),这对于G蛋白结合受体 (GPCR) 信号传输至关重要. 这些抑制剂阻断了βarr与GPCRs的相互作用,为研究细胞过程提供了新的工具.

    更多相关视频

    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
    09:03

    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

    Published on: March 10, 2020

    11.9K
    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
    07:16

    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

    Published on: August 16, 2018

    13.5K

    相关实验视频

    Last Updated: May 7, 2025

    Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
    08:21

    Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

    Published on: June 28, 2019

    6.8K
    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
    09:03

    Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

    Published on: March 10, 2020

    11.9K
    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
    07:16

    Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

    Published on: August 16, 2018

    13.5K

    科学领域:

    • 生物化学 生物化学
    • 药理学 药理学是指药理学的学科.
    • 结构生物学 结构生物学

    背景情况:

    • β-arrestins (βarrs) 是G蛋白合受体 (GPCRs) 的关键调节者,影响着各种生理过程.
    • 目前的药物发现缺乏针对βarrs的特定工具,与GPCR或G蛋白不同.

    研究的目的:

    • 发现和描述βarrs.的新型小分子全抑制剂.
    • 阐明βarr抑制的作用机制和结构基础.

    主要方法:

    • 生物物理,生物化学和药理学分析.
    • 电子显微镜 (cryo-EM) 用于结构的确定.
    • 分子动力学 (MD) 模拟和突变发生研究.

    主要成果:

    • 识别破坏βarr-GPCR相互作用的小分子,损害受体内化和脱敏.
    • 与抑制剂Cmpd-5复合的βarr1的冷-EM结构揭示了密码裂中的结合,作为分子锁.
    • 抑制剂结合会诱导一种独特的βarr1构造,阐明了全抑制机制.

    结论:

    • 已经开发出了新的βARRS小分子全抑制剂.
    • 这些抑制剂为研究GPCR依赖和独立通路中的βarr函数提供了新的药理工具.
    • 对Cmpd-5结合的结构洞察力为设计未来β-arr向治疗提供了基础.